This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
EV-302
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASCO GU 2025
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
ASCO GU 2024
ASCO GU 2024 Prostate Cancer
ASCO GU 2024
Prostate Cancer
Bladder Cancer
Kidney Cancer
Penile, Urethral, Testicular, and Adrenal Cancers
Upper Tract Urothelial Carcinoma
Press Releases
ASCO GU 2024 Prostate Cancer
Viewing 10481-10500 of 11881 articles
#AUA15 - Decline in the use of radiation for stage I seminoma: Analysis of the National Cancer Database - Session Highlights
#AUA15 - Helical ureteral stents results in less analgesic use compared to control stents - Session Highlights
#AUA15 - 3D printed physical models of renal malignancies for operative planning and surgical simulation - Session Highlights
#AUA15 - Current status of focal therapy modalities for prostate cancer - Session Highlights
#AUA15 - 3D printing of urological malignancies - Session Highlights
#AUA15 - The new frontier of prostate cancer imaging, beyond multi-parametric MRI - Session Highlights
#AUA15 - The current and emerging role of renal biopsy for the renal mass - Session Highlights
#AUA15 - MRI/US fusion for diagnosis and treatment of prostate cancer in the office setting - Session Highlights
#AUA15 - Prostate cancer biomarkers for tailored therapy: Value added or only cost - Session Highlights
#AUA15 - Pathologic assessment at the time of TURBT: Can your initial pathologic report be trusted when making treatment decisions - Session Highlights
#AUA15 - What genomic research tells us about treating prostate cancer - Session Highlights
#AUA15 - Technical solutions to improve the management of non-muscle invasive transitional cell carcinoma - Session Highlights
#AUA15 - Role of screening VCUG to evaluate for posterior urethral valves in infant males with bilateral hydronephrosis - Session Highlights
#AUA15 - Urethrocutaneous fistula development after hypospadias repair is associated with caudal anesthesia - Session Highlights
#AUA15 - Treatment of persistent urinary incontinence in children with occult tethered cord syndrome by section of the filum terminale: A randomized controlled pilot study - Session Highlights
#AUA15 - Are certain children more likely to have complications after sacral neuromodulation? - Session Highlights
#AUA15 - A mass spectrometry-based approach to identify environmental endocrine disruptors in the development of hypospadias - Session Highlights
#AUA15 - Outcomes of single stage vs. two-stage sacral neurostimulation in children with bowel and bladder dysfunction - Session Highlights
#AUA15 - Antimicrobial utilization prior to endourological surgery for urolithiasis: Endourological Society survey results - Session Highlights
#AUA15 - Impact of delaying treatment for kidney stones
520
521
522
523
524
525
526
527
528
529
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free